Opportunity Information: Apply for RFA DK 13 507
Apply for RFA DK 13 507
- The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Limited Competition of the MAPP Research Network(U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.313 NIH Office of Research on Womens Health 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
- This funding opportunity was created on Aug 23, 2013 and posted on Aug 22, 2013.
- Applicants must submit their applications by Nov 27, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $7,000,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 6 candidate(s).
- Eligible applicants include: For profit organizations other than small businesses Small businesses Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education State governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Limited Competition of the MAPP Research Network (U01) funding opportunity (RFA-DK-13-507) is a National Institutes of Health cooperative agreement designed to continue and expand the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network for a second five-year project period. The MAPP Network focuses on urologic chronic pelvic pain syndromes (UCPPS), specifically interstitial cystitis/bladder pain syndrome (IC/BPS) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). At its core, the program is built around multi-center collaboration to deepen understanding of the causes, progression, and risk factors for these conditions, with the practical intent of creating a translational foundation that can later support better interventions and improved clinical management.
The Network structure described in the announcement includes six Discovery Sites responsible for clinical research activities, along with two specialized cores: a Data Coordinating Core (DCC) that manages and harmonizes data across the consortium, and a Tissue and Technology Core (TATC) that supports biological sample handling and related technology needs. The second project period is intended to build directly on work completed in the first period by continuing analyses of already collected clinical datasets and performing additional assays on previously collected biological specimens. In parallel, the Network is expected to design, develop, and implement a second phase of collaborative research protocols, meaning new or expanded studies coordinated across participating sites rather than isolated, single-institution projects.
A major emphasis of this continuation is resource building for the broader research community. Beyond producing findings, the Network is expected to generate and curate a sharable resource of clinical data and biological samples so other investigators can use these materials to accelerate future discovery. In practical terms, this positions the MAPP Network not only as a research producer but also as a platform that creates standardized, high-value datasets and biospecimen collections that can support additional studies in chronic pelvic pain and related mechanisms.
This is a limited competition announcement, meaning it is not open to entirely new teams seeking to join the Network from scratch. Instead, NIH is specifically inviting applications from existing MAPP Discovery Sites and Core Sites to compete for continued support during the second five-year period. The mechanism is a U01 cooperative agreement, which typically indicates substantial NIH program involvement in coordination, oversight, and collaboration, consistent with large, multi-site network science where harmonized protocols, shared infrastructure, and centralized governance are necessary.
In terms of funding and administrative details, the announcement anticipated around six awards with an estimated total funding level of approximately $7,000,000. The posting date was August 22, 2013, with an original and current closing date of November 27, 2013, and an archive date of December 28, 2013. There is no cost sharing or matching requirement stated. The opportunity is associated with CFDA numbers 93.313 (related to NIH/NIDDK extramural research in diabetes, digestive, and kidney diseases) and 93.847 (NIH Office of Research on Women’s Health), reflecting the clinical and cross-cutting relevance of chronic pelvic pain conditions, including their significant impact on women’s health.
Eligibility in the government-wide listing is broad (including universities, nonprofits, small businesses, tribal entities, state and local governments, and some foreign components), and it explicitly notes that foreign organizations and foreign components are allowed under NIH policy. However, the practical eligibility constraint that matters most here is the limited competition requirement: applications are intended for the current MAPP Network Discovery and Core Sites seeking renewal/continuation into the second project period. For applicants and stakeholders needing the complete requirements, the full announcement was hosted on the NIH Grants Guide, and NIH provided webmaster contacts for access or linking issues.
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This opportunity is the Limited Competition of the MAPP Research Network (U01) funding opportunity, RFA-DK-13-507. It is a National Institutes of Health (NIH) cooperative agreement intended to continue and expand the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network for a second five-year project period.
What does MAPP stand for?
MAPP stands for the Multidisciplinary Approach to the Study of Chronic Pelvic Pain. The MAPP Research Network is organized to conduct collaborative, multi-center research on chronic pelvic pain conditions.
What conditions does the MAPP Network focus on?
The Network focuses on urologic chronic pelvic pain syndromes (UCPPS), specifically interstitial cystitis/bladder pain syndrome (IC/BPS) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
What is the main goal of the second five-year project period?
The second project period is designed to build directly on the first period by continuing analyses of already collected clinical datasets, performing additional assays on previously collected biological specimens, and developing and implementing a second phase of collaborative research protocols across participating sites.
What is meant by a "limited competition" announcement?
A limited competition means the opportunity is not open to brand-new teams joining the Network for the first time. NIH is specifically inviting applications from existing MAPP Discovery Sites and Core Sites to compete for continued support in the second project period.
Who is eligible to apply?
The government-wide eligibility listing is broad (for example: universities, nonprofits, small businesses, tribal entities, and state and local governments, and some foreign components). However, the key practical eligibility restriction is that this is a limited competition intended for current MAPP Network Discovery Sites and Core Sites seeking renewal/continuation.
Are foreign organizations or foreign components allowed?
Yes. The listing notes that foreign organizations and foreign components are allowed under NIH policy. At the same time, the limited competition requirement still applies (the invitation is aimed at existing MAPP Network Discovery and Core Sites).
What is a U01 cooperative agreement, and why does it matter here?
A U01 is a cooperative agreement mechanism, which generally indicates substantial NIH program involvement in coordination, oversight, and collaboration. This fits a large, multi-site network model where harmonized protocols, shared infrastructure, and centralized governance are important.
How is the MAPP Research Network structured under this announcement?
The Network structure described includes six Discovery Sites that carry out clinical research activities, plus two specialized cores: a Data Coordinating Core (DCC) and a Tissue and Technology Core (TATC).
What do the Discovery Sites do?
Discovery Sites are responsible for clinical research activities within the Network, operating as part of a coordinated, multi-center collaboration rather than isolated single-institution projects.
What does the Data Coordinating Core (DCC) do?
The DCC manages and harmonizes data across the consortium, supporting coordinated analyses and consistent handling of Network-wide clinical research data.
What does the Tissue and Technology Core (TATC) do?
The TATC supports biological sample handling and related technology needs, enabling the Network to work with biospecimens in a coordinated way.
Will the second project period use data and samples collected in the first period?
Yes. The second project period is expected to continue analyses of clinical datasets already collected and perform additional assays on biological specimens previously collected.
Is the Network expected to start new studies during the second project period?
Yes. In parallel with continued analyses of existing resources, the Network is expected to design, develop, and implement a second phase of collaborative research protocols coordinated across participating sites.
What is the translational intent of the program?
The program aims to deepen understanding of causes, progression, and risk factors for UCPPS, with the practical intent of creating a translational foundation that can later support improved interventions and better clinical management.
What is meant by "resource building" for the broader research community?
Beyond producing findings, the Network is expected to generate and curate sharable clinical data and biological sample resources so other investigators can use them to accelerate future discovery in chronic pelvic pain and related mechanisms.
How many awards were anticipated?
The announcement anticipated around six awards.
What was the estimated total funding level?
The estimated total funding level was approximately $7,000,000.
Is cost sharing or matching required?
No cost sharing or matching requirement is stated in the information provided.
When was this opportunity posted?
The posting date was August 22, 2013.
What were the closing date and archive date?
The original and current closing date was November 27, 2013, and the archive date was December 28, 2013.
What are the CFDA numbers associated with this opportunity?
The opportunity is associated with CFDA numbers 93.313 and 93.847.
What do the CFDA numbers indicate in this context?
CFDA 93.313 is related to NIH/NIDDK extramural research in diabetes, digestive, and kidney diseases, and CFDA 93.847 is associated with the NIH Office of Research on Women’s Health, reflecting the clinical relevance of chronic pelvic pain conditions and their significant impact on women’s health.
Where was the full announcement hosted, and what if someone has access issues?
The full announcement was hosted on the NIH Grants Guide. NIH also provided webmaster contacts for access or linking issues.
Browse more opportunities from the same category: Food and Nutrition Health
Next opportunity: Expansion of the MAPP Research Network (U01)
Previous opportunity: Maps of W R
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DK 13 507
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DK 13 507) also looked into and applied for these:
| Funding Opportunity |
|---|
| Expansion of the MAPP Research Network (U01) Apply for RFA DK 13 025 Funding Number: RFA DK 13 025 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $250,000 |
| Developmental Centers for Interdisciplinary Research in Benign Urology (P20) Apply for RFA DK 13 019 Funding Number: RFA DK 13 019 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Translational Research to Improve Diabetes and Obesity Outcomes (R01) Apply for PA 13 352 Funding Number: PA 13 352 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Harvesting the Neuroimaging Cornucopia for Pancreatic Islet Imaging Reagents for Diabetes Research (DP3) Apply for RFA DK 13 024 Funding Number: RFA DK 13 024 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $300,000 |
| Human Islet Research Network Coordinating Center (U01) Apply for RFA DK 13 013 Funding Number: RFA DK 13 013 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $1,000,000 |
| Human Islet Research Network Bioinformatics Center (U01) Apply for RFA DK 13 014 Funding Number: RFA DK 13 014 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $333,000 |
| Consortium on Targeting And Regeneration (CTAR) HIRN (UC4) Apply for RFA DK 13 015 Funding Number: RFA DK 13 015 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $600,000 |
| Consortium on Human Islet Biomimetics (CHIB) HIRN (UC4) Apply for RFA DK 13 016 Funding Number: RFA DK 13 016 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $1,200,000 |
| Consortium on Modeling Autoimmune Interactions (CMAI) HIRN (UC4) Apply for RFA DK 13 017 Funding Number: RFA DK 13 017 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $600,000 |
| Consortium on Beta cell Death and Survival (CBDS) HIRN (UC4) Apply for RFA DK 13 018 Funding Number: RFA DK 13 018 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $600,000 |
| Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18) Apply for PAR 13 365 Funding Number: PAR 13 365 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $500,000 |
| Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R18) Apply for PAR 13 366 Funding Number: PAR 13 366 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $500,000 |
| Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R34) Apply for PAR 13 367 Funding Number: PAR 13 367 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $150,000 |
| Novel Methods for Detection and Measurement of Organ Fibrosis in Kidney, Bone Marrow and Urological Diseases (U01) Apply for RFA DK 13 026 Funding Number: RFA DK 13 026 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $250,000 |
| Biomarkers for Diabetes Complications Non Invasive Measures in the Eye (DP3) Apply for RFA DK 13 027 Funding Number: RFA DK 13 027 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $1,000,000 |
| Limited Competition for the Data Coordinating Center for Type I Diabetes TrialNet (UC4) Apply for RFA DK 13 508 Funding Number: RFA DK 13 508 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| George M. OBrien Urology Cooperative Research Centers Program (U54) Apply for RFA DK 13 020 Funding Number: RFA DK 13 020 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $1,000,000 |
| Seeding Collaborations for Translational Research to Discover and Develop New Therapies for Diseases and Conditions within NIDDKs Mission (Revisions) (R01) Apply for PAR 14 006 Funding Number: PAR 14 006 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $75,000 |
| Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artificial Pancreas (SBIR) (R43/R44) Apply for RFA DK 13 028 Funding Number: RFA DK 13 028 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Lead Optimization and Pre Clinical Development of Therapeutic Candidates for Diseases of Interest to NIDDK (STTR (R41/R42)) Apply for PA 14 054 Funding Number: PA 14 054 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 13 507", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.